Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | Harmonizing the implementation of immune monitoring post-CAR-T therapy

Simona Pagliuca, MD, PhD, Nancy University Hospital, Nancy, France, discusses the importance of immune monitoring following CAR-T therapy. Immune monitoring of the apheresis product, in particular levels of CD8+ T-cells, can be used to assess clinical responses and guide treatment decisions. A survey across centers in Europe found significant variability in practices, emphasizing the need for standardized immune monitoring post-CAR-T therapy. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.